Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000318306-15-000036
Filing Date
2015-06-19
Accepted
2015-06-19 17:47:07
Documents
1
Period of Report
2015-05-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1444
  Complete submission text file 0000318306-15-000036.txt   3104
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4848 LEMMON AVENUE, SUITE 517 DALLAS TX 75219
Business Address
Wider Todd (Reporting) CIK: 0001642715 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15771 | Film No.: 15943255